CTNM
UNKNOWNContineum Therapeutics, Inc.
CIK: 0001855175
Last activity: Mar 2, 2026
Financial Metrics
As of Dec 31, 2025 (10-K)
Insider Roster (3 total, 3 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
|
Lorrain Daniel S.
Chief Scientific Officer
|
0 | 10 | -$358K |
151,882 shares
$2.28M
|
|
Watkins Tim
CMO & Head of Development
|
0 | 4 | -$149K |
Holdings: -
Value: -
|
|
Stengone Carmine N.
CEO and President
|
0 | 3 | -$120K |
14,954 shares
$239K
|
Recent Transactions
4,170 shares @ $15.01
$63K
Mar 2, 2026
3,611 shares @ $15.02
$54K
Mar 2, 2026
3,824 shares @ $16.01
$61K
Feb 25, 2026
2,700 shares @ $16.02
$43K
Feb 25, 2026
4,400 shares @ $16.02
$70K
Feb 24, 2026
4,300 shares @ $16.03
$69K
Feb 24, 2026
100 shares @ $16.00
$2K
Feb 19, 2026
400 shares @ $16.00
$6K
Feb 11, 2026
400 shares @ $16.00
$6K
Feb 11, 2026
3,000 shares @ $14.82
$44K
Feb 3, 2026
1,170 shares @ $15.25
$18K
Feb 3, 2026
2,800 shares @ $14.09
$39K
Jan 28, 2026
811 shares @ $14.48
$12K
Jan 28, 2026
3,670 shares @ $10.35
$38K
Jan 5, 2026
500 shares @ $11.13
$6K
Jan 5, 2026
3,611 shares @ $12.06
$44K
Dec 29, 2025
4,170 shares @ $12.23
$51K
Dec 23, 2025
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.